These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15627669)

  • 1. Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C.
    Anand AC; Seth AK; Nagpal A; Varma PP; Gadela SR; Baliga KV; Dutta V; Chopra GS
    Indian J Gastroenterol; 2004; 23(6):226-7. PubMed ID: 15627669
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment strategies for chronic hepatitis C virus infection.
    Kasahara A
    J Gastroenterol; 2000; 35(6):411-23. PubMed ID: 10864347
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
    Tsubota A; Kumada H; Arase Y; Chayama K; Saitoh S; Ikeda K; Kobayashi M; Suzuki Y; Murashima N
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1077-83. PubMed ID: 10524635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.
    Li LF; Shi KQ; Lin YQ; Wang LR; He JP; Braddock M; Chen YP; Zheng MH
    Gene; 2014 Jul; 544(2):101-6. PubMed ID: 24793583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.
    van Rossum TG; Vulto AG; de Man RA; Brouwer JT; Schalm SW
    Aliment Pharmacol Ther; 1998 Mar; 12(3):199-205. PubMed ID: 9570253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin treatment in patients with chronic hepatitis C infection who had renal transplantation.
    Karaca C; Besisik F; Akyuz F; Dincer D; Sever MS; Okten A
    Dig Surg; 2005; 22(1-2):113. PubMed ID: 15849473
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
    Calanca LN; Fehr T; Jochum W; Fischer-Vetter J; Müllhaupt B; Wüthrich RP; Ambühl PM
    J Clin Virol; 2007 May; 39(1):54-8. PubMed ID: 17409018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
    Fabrizi F; D'Ambrosio R; Pallotti F; Berardinelli L; Messa P; Martin P; Aghemo A
    Int J Artif Organs; 2014 Nov; 37(11):803-8. PubMed ID: 25362901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C.
    Fontaine H; Vallet-Pichard A; Equi-Andrade C; Nalpas B; Verkarre V; Chaix ML; Lebray P; Sobesky R; Serpaggi J; Kreis H; Pol S
    Transplantation; 2004 Sep; 78(6):853-7. PubMed ID: 15385804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
    Knapstein J; Galle PR; Zimmermann T
    Dig Liver Dis; 2014 Jan; 46(1):88-9. PubMed ID: 24054768
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients.
    Taneja S; Duseja A; De A; Kumar V; Ramachandran R; Sharma A; Dhiman RK; Gupta KL; Chawla Y
    Nephrology (Carlton); 2018 Sep; 23(9):876-882. PubMed ID: 28703905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.
    Scott LJ; Perry CM
    Drugs; 2002; 62(3):507-56. PubMed ID: 11827565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of hepatitis C: from empiricism to eradication.
    Pawlotsky JM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S207-20. PubMed ID: 16447262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
    García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
    Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
    Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
    PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis C in haemodialysis patients requires more ribavirin.
    Slavenburg S; Drenth JP
    Nephrol Dial Transplant; 2008 Jul; 23(7):2430; author reply 2430-1. PubMed ID: 18400821
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic hepatitis C--ribavirin plus interferon versus interferon. An analysis of a systematic Cochrane review].
    Laursen AL; Vilstrup H
    Ugeskr Laeger; 2006 Nov; 168(48):4209-12. PubMed ID: 17147946
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.
    Samuel D; Bizollon T; Feray C; Roche B; Ahmed SN; Lemonnier C; Cohard M; Reynes M; Chevallier M; Ducerf C; Baulieux J; Geffner M; Albrecht JK; Bismuth H; Trepo C
    Gastroenterology; 2003 Mar; 124(3):642-50. PubMed ID: 12612903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
    Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
    Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.